Firstly, since cblC deficiency is the disease involving intracellular cobalamin metabolism, OHCbl, as the etiologic therapy, is the leading and indispensable treatment for this disease. The gene discussed is CBLC; the disease is hyperinsulinemic hypoglycemia, familial, 4.